EPCAM and hepatocellular carcinoma: As expected, silencing of ZFX attenuated the transcriptional activation of β‐catenin, as revealed by the decreased luciferase activity in shZFX‐stable EpCAM+ HCC cells compared with the control (Fig. 6C).